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Background: Data extraction is a key stage in systematic review, yet it is the subject of little research. The aim of
the present research was to use a small case study to highlight some important issues affecting this fundamental
process.
Methods: The authors undertook an analysis of differences in the binary event data extracted and analysed by
three systematic reviews on the same topic: a comparison of total hip arthroplasty and hemiarthroplasty. The
following binary event data were extracted for three key outcomes, common to all three reviews, from those trials
common to all three reviews: Dislocation rates, 1-year mortality, and revision rates. Differences between the data
extracted by the three reviews were categorised as either errors or an issue of data selection. Meta-analysis was
performed to assess whether these differences led to differences in summary estimates of effect.
Results: Across the three outcomes, differences in selection accounted for between 8% and 42% of the data
differences between reviews, and errors accounted for between 8% and 17%. No rationale was given in any of
these former cases for the choice of event data being reported. These differences did lead to small differences in
meta-analysed relative risks between the two treatments in the three reviews, but none was significant.
Conclusions: Systematic reviewers should use double-data extraction to minimise error and also make every effort
to clarify or explain their choice of data, within the scope of their publication. Reviewers frequently exercise
selection when faced with a choice of alternative but potentially equally appropriate data for an outcome. However,
this selection is rarely made clear by review authors. Systematic review was developed as a method specifically to
be both reproducible and transparent. This case study suggests that neither objective is always being achieved.
Keywords: Systematic review, Data interpretation, Meta-analysis, Data extraction, Data-handling error, ReportingBackground
Data extraction or abstraction is a crucial stage in syste-
matic review. It is the stage that generates the data to be
analysed. However, it is a relatively under-researched area
of the systematic review process compared to information
retrieval, the assessment of bias, and methods of synthesis.
The little research that has been conducted has been fun-
damental in our understanding of some of the principal
limitations affecting the process. It has found that errors
in data extraction can occur frequently. One study found
errors in 20 of the 34 Cochrane reviews assessed, or error* Correspondence: c.carroll@shef.ac.uk
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reproduction in any medium, provided the orrates as high as 31% in one evaluation of data extraction
[1]. Data extraction errors may occur in all variables ex-
tracted for a review, but outcomes appear to generate the
most errors: such error rates have been found to be as
high as 77% [2]. Errors have been defined in various ways
in these studies, principally as inaccuracies, omissions, in-
adequacies and incomplete data [1,2]. Previous assess-
ments have covered all fields in data extraction, from
design and inclusion criteria to actual outcomes. Error
rates are apparently unaffected by reviewer experience [1],
but can be influenced to a small degree by the double data
extraction process [2]: that is, double data extraction can
lead to fewer errors, though reviewer experience itself
does not. Wherever it has been evaluated, it has beenLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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was not statistically significant.
The aim of the present work is to contribute to the
small amount of literature on this topic, which is actually
a time-consuming and crucial stage in the systematic re-
view process. In doing so it focuses only on key numerical
outcome data actually employed in a meta-analysis. This
approach was taken because these outcome data are more
likely to affect synthesis and findings than other data
extracted from a study, and because numerical data po-
tentially present less ambiguity than textual data, such as
inclusion or exclusion criteria or descriptions of measures.
Previous studies have reported that error rates are lower
when the variable is “simple”, such as authorship, country
of study, gender distribution and numbers enrolled,
where-as text variables, which can sometimes be lengthy,
such as inclusion and outcome assessment criteria, prove
more problematic [1,2]. Indeed, it has been found that
when data handling is particularly complex, for example
calculating standardised mean differences (SMDs), in
order to permit meta-analysis of different scales using
continuous data, the scope for error is increased. [3] In
the case of simple binary numerical outcome data, how-
ever, the data extracted by two reviewers are quite simply
either the same or different. There is little or no scope for
variation. Any differences may therefore be explained in
two ways. First, they are “errors” over which there is no
question: one number alone is correct; any others are an
error. Second, differences in the data might be explained
by a factor otherwise only rarely considered by the re-
search on this topic [3], that a publication might offer a
number of equally viable data alternatives for extraction.
In other words, more than one possible answer exists, but
reviewers have to make a choice about which number they
considered to be the most appropriate.
This research therefore aimed first to identify diffe-
rences in the binary event data extracted and analysed
for three outcomes by three reviews on the same topic,
across trials common to all three reviews. The objective
was then to determine whether any such differences
were due either to reviewers simply choosing different,
potentially viable data from the primary study publica-
tions, or to outright errors of extraction. The impact of
these differences on final outcomes was also evaluated.
Finally, the implications of these findings for the imple-
mentation of systematic review methods, and the peer-
review of systematic reviews, is considered.
Methods
The authors conducted a systematic review of clinical ef-
fectiveness comparing total hip replacement versus hemi-
arthroplasty for the treatment of displaced intracapsular
hip fracture. This is published as a Health Technology
Assessment (HTA) [4]. An updated Cochrane review [5]and a British Medical Journal [BMJ] systematic review [6]
addressing a very similar question, and applying very simi-
lar or the same inclusion criteria, were published shortly
before the authors’ own review. The authors’ own HTA
report, and the other systematic reviews, therefore repre-
sented an opportunistic sample for conducting the current
small case study. These sources were considered to offer
useful evidence on the data extraction process because
they each represent a high-impact, highly accessed source
of systematic reviews. A fourth relevant review was identi-
fied [7], but does not form a key part of this evaluation be-
cause it is published in a relatively low-impact journal in
Chinese and does not include all of the studies or out-
comes. It is therefore referred to only where relevant.
An analysis was made of certain binary event data ex-
tracted for the following three key outcomes, common to
all three reviews: dislocation rates; one-year mortality
rates; and revision rates. These outcomes were all relatively
straightforward. Other outcomes, such as “reoperation” or
“any surgery”, which could include dislocations and other
alternative procedures were not used as they presented ob-
vious problems of definition. The data for analysis were
derived from the publications of those trials common to
all three reviews. Data on the three stated outcomes were
independently extracted from the included studies by the
three authors of this paper, and any discrepancies or dis-
agreements were discussed and consensus met, to create
the “HTA” data that acted as the “reference standard”. This
term is not intended as a judgment of quality, but rather
simply represents the baseline that was required for such
an evaluation. We chose to use our own HTA report as
the nominal reference standard for the comparisons, des-
pite being the most recent review, because it contained the
data we, as a group, had carefully selected and agreed.
However, in many ways, the choice of reference standard
did not matter; the principal outcome of interest was to
identify instances of inconsistency across the reviews,
which then needed to be explored with reference to the
original, primary studies. In reality, these provided the real
reference standard.
The data for analysis therefore consisted of the denomi-
nators and numerators for each outcome across two trial
arms (4 variables) in six studies common to each review.
This gave a total of 24 variables for each outcome, which
could be the same or different for each review. The results
presented below describe the percentage of differences
between the BMJ or Cochrane review and the HTA “refe-
rence standard” for any of the outcomes. Thus, if six of
the variables were different between, for example, the BMJ
and HTA reviews, that represented a 25% (6/24) dif-
ference. An investigation was then made to determine
whether alternative data existed, which might explain the
differences, and for which reviewers had been required to
make an explicit choice. Such differences were categorised
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rect, that is, the data extracted by a review did not reflect
any of the potential data reported in the original primary
studies, these were categorised as “errors”. Percentages are
reported for each category. The impact of data differences
on the summary estimates of effect using relative risks
(RR) was also calculated by meta-analysis using a random
effects model.
Results
A comparison of the three reviews’ extracted data for each
outcome and each relevant trial is shown in Tables 1, 2
and 3. The likely explanations of selections or errors are
given in the final column of each table.
For the dislocation outcome, the percentage of diffe-
rences due to the selection of alternative but potentially
valid data were 17% and 8% in the BMJ and Cochrane res-
pectively, where-as 8% were categorised as “errors” in both
reviews (2/24); (see Table 1). For the 1-year mortality out-
come, compared to the HTA report, the percentage of dif-
ferent data due to differences in selection was 42% andTable 1 Dislocation outcome data reported for THA (n/N) vs H
Study BMJ Cochrane H
Dorr 1986 [22] 7/39 vs 2/50 7/39 vs 2/50 7
Skinner 1989 [17] NR 10/80 vs 11/100 1
(1-year data)
Ravikumar 2000 [18] 18/91 vs 12/89 NR 1
(13-year data)
Baker 2006 [12] 3/40 vs 0/41 3/40 vs 0/41 3
Keating 2006 [11] 3/69 vs 3/111 3/69 vs 2/69 3
Blomfeldt 2007 [9] 0/60 vs 0/60 0/60 vs 0/60 0
Macaulay 2008 [23] 1/17 vs 0/23 1/17 vs 0/23 1
Mouzopoulos 2008 [8] NR NR N





*Liang has 8/91 here: an error. Otherwise Liang has the same data as the HTA. THA
Applicable. Findings are given in bold.25% in the BMJ and Cochrane reviews respectively, while
differences categorised as “errors” were 17% and 13% (see
Table 2). For the revision rates outcome, 21% and 25% of
data differences in the BMJ and Cochrane reviews, res-
pectively, compared to the HTA report, were due to selec-
tion, and 13% and 8% of different data were categorised as
“errors” (see Table 3).
The reasons for the differences between data could
often be easily ascertained and are described in the final
columns of Tables 1, 2 and 3. The explanation of those
differences categorised as “errors” was straightforward.
They were due either to errors in transposing data from
primary studies for analysis, or a failure to identify the cor-
rect data from the available publications. In this latter in-
stance, a best guess seems to have been used. However, it
was not always possible to see the rationale behind the se-
lection of other data, such as the 1-year mortality or revi-
sions data used in the BMJ review and extracted from the
trials reported by Mouzopoulos et al. [8] and Blomfeldt
et al. [9], respectively. This was only clarified by gaining a
response from the authors [10]. The differences in theA (n/N) in 3 reviews
TA Comments
/39 vs 2/50 Identical
1/89 vs 10*/91 Skinner and Ravikumar only report percentages
rather than event data and only Ravikumar
reports numbers in each trial arm (denominator)
Errors:
8/89 vs 12/91 BMJ denominators for the 2 groups are the
wrong way round; Cochrane generates its own
denominators having failed to identify
Ravikumar 2000 (follow-up to Skinner)
Selection difference:
Numerators are all incorrect due to calculations
based on percentages and incorrect
denominators.
/40 vs 0/41 Identical
/69 vs 2/69 Selection difference:
BMJ alone analyses HA data from a separate
trial arm (with 111 participants), but these data
from this arm arguably should not be included
in this analysis because different eligibility
criteria were being applied (i.e. the surgeons
and centres involved were either unwilling or
unable to have participants randomised to
THA).
/60vs 0/60 Identical
/17 vs 0/23 Identical
R NA
6 analysed studies = a/B vs c/D = 24
variables
, Total Hip Arthroplasty; HA, Hemiarthroplasty; NR, Not Reported; NA, Not
Table 2 Mortality data at 1 year reported for THA (n/N) vs HA (n/N) in 3 reviews
Study BMJ Cochrane HTA Comments




Dorr reports 7 deaths across both arms; BMJ review
categorises this as 3 and 4 in each arm [10]
Skinner 1989 [17] 21/91 vs 24/89 18/80 vs 27/100 20/89 vs 25/91 Error and Selection difference:
(1-year data) As Table 1 for these data
Ravikumar 2000 [18]
(13-year data)
Baker 2006 [12] NR NR NR NA
Keating 2006 [11] 4/69 vs 11/111 4/69 vs 6/69 4*/69 vs 6/69 Selection difference:
As Table 1
Blomfeldt 2007 [9] 4/60 vs 3/60 4/60 vs 3/60 4/60 vs 3/60 Identical
Macaulay 2008 [23] 1/17 vs 5/23 NR NR Selection difference:
BMJ analyses reported 6-month data as 1 year data;
Cochrane, HTA and Liang [7] all omit it from the 1-year
analysis; Cochrane analysis uses these data for 6-month
follow-up only. It is unclear when the additional deaths
reported for up to 2 years (4/17 vs 7/23) occurred. They
may have occurred in the 6–12 month period.
Mouzopoulos 2008 [8] 10/43 vs 13/43 6/43 vs 6/43 6/39 vs 6/38 Selection difference:
Denominators: HTA applied an intention-to-treat analysis,
excluding 4 from THA arm (2 data lost; 2 not satisfy
inclusion criteria) and 5 from HA arm (none satisfied trial’s
inclusion criteria), as they did not satisfy the study’s
inclusion criteria and no follow-up data were collected. [13]
If these are included, then explicit best and worst case
analyses perhaps should have been performed, with
imputations explained [14]





*Liang has 5/69 here: an error. Otherwise Liang has the same data as the HTA. THA,Total Hip Arthroplasty; HA, Hemiarthroplasty; NR, Not Reported; NA, Not
Applicable. Findings are given in bold.
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analysed relative risks between the two treatments in the
three reviews, but none was significant. See Table 4.
Discussion
Differences in data extracted due to selection were much
more frequent than differences due to errors. In each case,
a choice existed between various relevant outcome data,
so the reviewers had to make a decision about which data
to extract and use. However, the BMJ and Cochrane re-
views did not always make explicit the reasons for their
particular choice of data. For example, the BMJ review
chose to include data from an alternative arm in one trial
[11] and to include data relating to both hips, rather than
just the hip receiving the index procedure, for the revision
outcome in another trial [9]. In both instances, this led to
the review analysing data that were different from the
Cochrane review and the authors’ own HTA report, which
were identical. Alternatively, both the BMJ and HTA
reviews aggregated the reported “planned” as well as“completed” revisions data for the study by Baker et al.
[12] (this was explicitly reported by the HTA review),
while the Cochrane review only extracted and analysed
the former. The HTA review explicitly excluded partici-
pants from the 1-mortality data for Mouzopoulos et al. [8]
because the authors felt they should not have been rando-
mised, due to an implementation error [13], while the
Cochrane and BMJ reviews both included these partici-
pants. Good arguments could be made for any of these
choices. However, some selections might be deemed ra-
ther more questionable. Examples of this include the BMJ
review’s inclusion of revisions and exclusions as deaths,
without imputation for these missing data [14], and ex-
cessive extrapolation (6-month data as 1 year data) (see
Table 3 and [10]). In none of the above instances of selec-
tion did the Cochrane or BMJ reviews justify their selec-
tion decisions.
This is not a criticism of these reviews, but rather re-
flects a problem that is arguably endemic in published
examples of the systematic review method. After all, if
Table 3 Revision rates outcome data reported for THA (n/N) vs HA (n/N) in 3 reviews
Study BMJ Cochrane* HTA Comments
Dorr 1986 [22] 2/39 vs 4/50 2/39 vs 4/50 2/39 vs 4/50 Identical
Skinner 1989 [17] NR 3/80 vs 13/100 4/89 vs 12/91 As Table 1 above, plus an additional error: BMJ
calculates 25% rather than the reported 24% for
numerator(1-year data)
Ravikumar 2000 [18] 6/91 vs 22/89 NR 6/89 vs 22/91
(13-year data)
Baker 2006 [12] 1/40 vs 6/41 1/40 vs 3/41 1/40 vs 6/41 Selection difference:
BMJ, HTA and Liang [7] all report 1/40 vs 6/41;
Cochrane omits 3/41 which were classified as
planned or awaiting revision; the event had not
taken place but was “planned” only, so was not
counted
Keating 2006 [11] NR NR NR Identical
Blomfeldt 2007 [9] 4/60 vs 3/60 1/60 vs 0/60 0/60 vs 0/60 Selection difference:
Cochrane 1/60 is a “revision” described by
Blomfeldt as a “wound revision”; only revision of
implant counts as a revision in the HTA; the
BMJ review figures include re-operations both
on the contra-lateral side, not related to the
implant, and for trauma of the lower limb. [10]
Macaulay 2008 [23] 1/17 vs 0/23 1/17 vs 0/23 1/17 vs 0/23 Identical
Mouzopoulos 2008 [8] 1/43 vs 3/43 1/43 vs 5/43 1/39 vs 5/38 Selection difference:
Numerators: BMJ “excluded” 2 HA revisions from
the analysis (so 3 rather than 5) but this was
arguably not justified as the individuals had the
outcome of interest and so should have been
included;
Denominators: As Table 2.






*Revisions in Cochrane are categorised as “Major reoperations”. Findings are given in bold.
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nable choice, then they arguably would not feel the need
to record this. The data might seem the only reasonable
data to extract. However, the lack of transparency over the
data being extracted and analysed in reviews has been
raised as an issue before [3] and it is our contention that,
as reviewers, we are expected to be explicit and transpa-
rent in our actions and choices. The GRADE group have
recently called for reviewers to provide greater clarity
in their decisions regarding assessments of risk of bias:Table 4 Risk of outcomes for THA vs HA using the data repor
Outcome HTA Co
Dislocation 1 year: 1.70 (0.91, 3.19), p = 0.10 1 y
13 years: 1.93 (1.10, 3.37), p = 0.02
Mortality at 1 year 0.85 (0.57, 1.29), p = 0.45 0.87
Required revision 1 year: 0.38 (0.18, 0.81), p = 0.01 1 y
13 years: 0.33 (0.17, 0.64), p = 0.001
A random effects model was used for all analyses. Statistical heterogeneity of I2 = 0
*I2 = 23%; THA, Total Hip Arthroplasty; HA, Hemiarthroplasty; RR, Risk ratio; CI, Confireviewers should make explicit their reasons for a par-
ticular judgement. [15] We feel that an appeal for similar
clarity is required for the data extraction process. The re-
cording of a decision, when one has been made, should
form a part of both the process and the reporting of sys-
tematic reviews.
The incidence of errors appears to be low based on
this small case study sample. They appear to occur prin-
cipally due to human error, although double data extrac-
tion should minimise the chance of such bias or randomted in the 3 reviews (RR, 95% CI), p value
chrane BMJ
ear: 1.71 (0.91, 3.21), p = 0.10
13 years: 1.88 (1.08, 3.26), p = 0.03
(0.57, 1.32), p = 0.51 0.80 (0.56, 1.14), p = 0.22
ear: 0.40 (0.18, 0.89), p = 0.02
13 years: 0.47 (0.22, 1.01)*, p = 0.05
% for all analyses, except where specified.
dence Interval.
Carroll et al. BMC Research Notes 2013, 6:539 Page 6 of 7
http://www.biomedcentral.com/1756-0500/6/539error [16]. Both the BMJ and Cochrane reviews reported
using this approach, and the number of errors was indeed
relatively small, usually no more than 8% of the data for
any of the three outcomes assessed. The majority of these
instances related to one study [17,18] and were either
transposition errors when inputting the data into statis-
tical software [10] or were errors in calculating review data
from primary study data: the outcomes in the primary
study publication were only reported as percentages and
the numbers in each arm were only reported in one of the
two papers reporting the study (and this second paper was
missed by one of the reviews). Errors of transposition and
calculation have been identified as a problem previously
[3,19], although it has also been pointed-out that these
should not occur if at least two reviewers are involved [3].
The relatively small number of errors also fits with pre-
vious findings that error rates are lower when the variable
is “simple”, such as here. [1,2] Also, in each of these in-
stances the impact on the actual overall results was very
small because the proportion of events was often correct
(a key factor in the analysis), even if the actual numerators
and denominators extracted were incorrect.
Double data extraction is the obvious facilitator here
and is the recommended method [20]. This is because it
not only controls for random error, but can also high-
light the presence of data choices since, where a choice
exists, the scope for variation in extraction is higher. In
the context of completing reviews to time and cost [21],
where double-data extraction might not be feasible, “in-
dependent verification” [1] or double-checking of key
outcome data by a second reviewer might offer a more
rapid and pragmatic approach. While double data ex-
traction can be very time-consuming and has actually
been found not to produce large or significant differ-
ences in comparison with single data extraction [2], the
simple checking of data for analysis alone may represent
a reasonable way forward.
Finally, the journal peer-review process should perhaps
also involve some scrutiny of extraction to determine if
errors or selection has occurred. Currently, peer reviewers
accept the data as given. The introduction of a process of
double-checking for at least of sample of the extracted
data in any review submitted for publication may produce
a Hawthorne effect: errors might be avoided and selec-
tions justified if authors know their work is to be scru-
tinised. However, single extraction has been shown to
produce errors even in specific pieces of research testing
for data extraction error [1,2]. While the assessments of
data extraction published so far have admittedly found
that many extraction errors make little difference to
bottom-line outcomes, this is no reason not to do under-
take such processes in review and peer-review. After all,
something is always better if it is true, or if it at least
allows readers to judge a review’s decisions for themselves.The principal limitation of this research is that is an op-
portunistic small study, which has only compared three
reviews and their binary event data. A much larger study
or a study of a different topic might find that the fre-
quency of both errors and differences of selection is lower.
Alternatively, a comparison of a topic with more complex
outcomes might produce even higher rates of difference
in error or selection: an assessment of data extracted to
calculate standardised mean differences (SMD) identified
frequent and sometimes large errors [3]. The findings of
this present study are not generalisable to all reviews, but
serve to highlight the issue of interpretation and selection
that potentially affects data extraction and, consequently,
analysis in standard effectiveness reviews using quantita-
tive methods. This problem has otherwise only been com-
mented on in a single study [3]; the present case study
extends that work and illuminates the issue further. How-
ever, more research on this topic is needed.
Conclusion
Data extraction is not a straightforward objective process
without complexity. The capacity for errors to occur is
well known, while there has been comparatively little re-
cognition of the capacity of reviewers to make different
but equally justifiable choices in data selection. These are
not “errors” as such, but they are certainly a fact of con-
ducting reviews. Such choices can affect a review’s results.
In cases where some of the event data being analysed by a
review might be viewed as being open to question, i.e. a
matter of selection or interpretation, reviewers should
make every effort to clarify or explain their choice of out-
come data, within the scope of their publication. Double
data extraction can help control both for errors and to
identify issues of selection. Systematic review was de-
veloped as a method specifically to be reproducible and
transparent. The integrity and robustness of the method
can only benefit from the full application of such processes.Competing interests
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